cefcanel daloxate has been researched along with cephalosporin c in 9 studies
Studies (cefcanel daloxate) | Trials (cefcanel daloxate) | Recent Studies (post-2010) (cefcanel daloxate) | Studies (cephalosporin c) | Trials (cephalosporin c) | Recent Studies (post-2010) (cephalosporin c) |
---|---|---|---|---|---|
10 | 2 | 0 | 20,476 | 2,093 | 4,152 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlqvist, J; Lanbeck-Vallén, K | 1 |
Lionell, C; Magni, L | 1 |
Kakeya, N; Nakamura, S; Nishimura, K; Nishimura, M; Nishizawa, S; Yoshimi, A | 1 |
Hashimoto, E; Hashizume, H; Hatano, S; Kakeya, N; Kasai, M; Muro, H; Nishimura, K; Nishizawa, S; Yamada, T; Yoshimi, A | 1 |
Hashizume, H; Nishino, T; Obana, Y; Yoshimi, A | 1 |
Kakeya, N; Kitao, K; Mori, T; Nishimura, K; Nishizawa, S; Tamaki, S; Yoshimi, A | 1 |
Köhler, W; Schenk, P | 1 |
Dahl, K; Edwall, B; Slettevold, L; Thurmann-Nielsen, E; Torrång, A; Walstad, R | 1 |
Floor, M; Hoepelman, AI; Nicolle, LE; Norgard, K; Verhoef, J | 1 |
2 trial(s) available for cefcanel daloxate and cephalosporin c
Article | Year |
---|---|
[Cephalosporin treatment of maxillary sinusitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cephalosporins; Double-Blind Method; Female; Haemophilus Infections; Humans; Male; Maxillary Sinusitis; Middle Aged; Prodrugs | 1995 |
Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Middle Aged; Prospective Studies; Treatment Outcome; Urinary Tract Infections | 1993 |
7 other study(ies) available for cefcanel daloxate and cephalosporin c
Article | Year |
---|---|
Determination of cefcanel in plasma and urine by high-performance liquid chromatography using coupled columns, after administration of the new cephalosporin prodrug cefcanel daloxate hydrochloride.
Topics: Cefazolin; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Prodrugs; Specimen Handling | 1992 |
In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
Topics: Absorption; Animals; Bacterial Infections; Cefaclor; Cephalosporins; Disease Models, Animal; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prodrugs; Staphylococcal Infections | 1990 |
KY-109, a new bifunctional prodrug of cephalosporin. II. Mechanism of oral absorption.
Topics: Administration, Oral; Animals; Cephalosporins; Intestinal Absorption; Male; Prodrugs; Rats; Rats, Inbred Strains | 1988 |
[Study on orally active cephalosporin pro-drug. Synthesis, oral absorption and antibacterial activity of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 7-[D-O-(aminoacyl)mandelamido]-3-[[(5-methyl-1,3,4-thiadiazol -2-yl)-thio]methyl]-3-cephem-4-carboxylates].
Topics: Animals; Cefazolin; Cephalosporins; Intestinal Absorption; Mice; Prodrugs; Respiratory Tract Infections; Structure-Activity Relationship; Urinary Tract Infections | 1988 |
In vitro and in vivo antibacterial activity of KY-109, a new orally active cephalosporin.
Topics: Administration, Oral; Animals; Bacterial Infections; Cephalosporins; Male; Mice; Microbial Sensitivity Tests; Rabbits; Rats; Rats, Inbred Strains; Urinary Tract Infections | 1988 |
KY-109, a new bifunctional pro-drug of a cephalosporin. Chemistry, physico-chemical and biological properties.
Topics: Administration, Oral; Animals; Cephalosporins; Chemical Phenomena; Chemistry; Drug Stability; Intestinal Absorption; Rats | 1985 |
Pharmacokinetics of oral cefcanel daloxate hydrochloride in healthy volunteers and patients with various degrees of impaired renal function.
Topics: Administration, Oral; Adult; Aged; Cephalosporins; Chromatography, High Pressure Liquid; Female; Glomerular Filtration Rate; Half-Life; Humans; Iohexol; Male; Metabolic Clearance Rate; Middle Aged; Prodrugs; Renal Insufficiency | 1994 |